Cerus reported $180K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.





Ordinary Share Capital Change Date
GRIFOLS EUR 680.58M 0 Sep/2026
Haemonetics USD 45.52M 53K Sep/2026
Neogen USD 218.3M 600K Jun/2026
OraSure Technologies USD 70.39M 1.87M Dec/2025
Plus Therapeutics USD 275K 138.4M Mar/2026
Quidel USD 68.3M 200K Jun/2026
STAAR Surgical USD 50.2M 78K Sep/2026
Terumo JPY 1.48B 19K Jun/2026
Utah Medical Products USD 3.18M 2K Mar/2026